The chronological lifespan of budding yeast is a model of aging and age-related 2 diseases. This paradigm has recently allowed genome-wide screening of genetic factors 3 underlying post-mitotic viability in a simple unicellular system, which underscores its 4 potential to provide a comprehensive view of the aging process. However, results from 5 different large-scale studies show little overlap and typically lack quantitative resolution 6 to derive interactions among different aging factors. We previously introduced a 7 sensitive, parallelizable approach to measure the chronological-lifespan effects of gene 8 deletions based on the competitive aging of fluorescence-labeled strains. Here, we 9 present a thorough description of the method, including an improved multiple-regression 10 model to estimate the association between death rates and fluorescent signals, which 11 accounts for possible differences in growth rate and experimental batch effects. We 12 illustrate the experimental procedure-from data acquisition to calculation of relative 13 survivorship-for ten deletion strains with known lifespan phenotypes, which is achieved 14 with high technical replicability. We apply our method to screen for gene-drug 15 interactions in an array of yeast deletion strains, which reveals a functional link between 16 protein glycosylation and lifespan extension by metformin. Competitive-aging screening 17 coupled to multiple-regression modeling provides a powerful, straight-forward way to 18 identify aging factors in yeast and their interactions with pharmacological interventions.
INTRODUCTION
A major challenge in aging research is to describe the way in which different genetic 21 pathways and biochemical processes mediating aging are interconnected to one 22 another (Kirkwood, 2008; López-Otín et al., 2013) . Simple cellular models provide a 23 of a set of 76 deletion strains was measured with and without 40 mM metformin. 140 Deletion strains were randomly selected from the yeast deletion collection, considering 141 only genes with a mammalian ortholog (Ensembl). Relative survivorship values were 142 rescaled to a dimensionless parameter, given that metformin increases yeast CLS and 143 that the relative survivorship expressed in days is constrained by the death rate of the 144 wild-type reference, , which is different in each condition. based on outgrowth kinetics of single-population aging cultures were adapted from a 151 9 well established high-throughput method (Murakami et al., 2008; Jung et al., 2015) . 152 Culture density was monitored by measuring absorbance at OD 600nm ; background 153 signal-OD 600 at outgrowth inoculation-was subtracted to each data point. At each 154 aging sampling point (days), the time-shift in hours, , to reach a fixed cell density of 155 OD 600 =0.35 reports for the remaining fraction of viable cells in the population, as 156 previously reported (Murakami et al., 2008) . Specifically, for each successive age time Relative survivorship in stationary phase can be estimated from bulk 174 fluorescence signal of two populations in co-culture 175 We sought to optimize data analysis and systematically test a competition-based 176 method aimed at describing CLS phenotypes of viable gene-deletion strains in budding 177 yeast. To directly measure the lifespan effects, we tracked changes in the relative 178 abundances of RFP-deletion (x RFP ) and CFP-tagged wild-type (WT CFP ) strains in co-179 culture, as a function of time in stationary phase (T, days) ( Figure 1A) . To this end, we 180 inoculated stationary-phase cells at different time points into fresh medium and 181 monitored the outgrowth at multiple times (t, hours) by measuring absorbance at 600nm 182 (OD 600 ), bulk RFP signal (RFP), and bulk CFP signal (CFP), until the outgrowth co-183 cultures reached saturation.
184
We characterized the CLS of ten deletion strains that are known to show increased or 185 decreased lifespan (Fabrizio and Longo, 2003; Wei et al., 2008; Alvers et al., 2009; 186 Laschober et al., 2010; Burtner et al., 2011; Garay et al., 2014; Campos et al., 2018) . (Figure 1B) . This prevalent shift in growth kinetics reflects the loss of viability 193 with culture age, as previously described (Murakami et al., 2008) . 194 
11
In terms of fluorescence-signal kinetics, we observed that the WT RFP or WT CFP 195 monocultures mostly recapitulated OD 600 kinetics, suggesting that loss of viability can 196 also be measured by the shift of the fluorescence signal over the days (Figure 1B , red 197 and blue lines). WT RFP +WT CFP populations competed in co-culture showed similar shifts 198 in fluorescence signals, suggesting that loss of viability occurred at similar rates in both 199 wild-type populations, as expected (Figure 1B, along with that of the other three parameters for competing populations are illustrated in 219 Figure 2 . The expected value, , is the logarithmic quotient of the sizes of the 220 populations of x RFP and WT CFP from an outgrowth inoculated at day in stationary 221 phase and measured after hours in the outgrowth culture (Supplementary Note S1).
222
The parameter is the difference in death rates ( are likely due to systematic errors in the measurements. It must be noted that there are 232 usually survivorship and growth-rate differences between the two wild-type strains 233 (WT RFP and WT CFP ), which are taken into account while fitting the data. For instance, in 234 this experiment the WT RFP (and isogenic deletion strains) die faster than the WT CFP 235 reference used, which is evident from the negative slope of data points in Fig 2A; survivorship. We also show that this procedure is useful to identify CLS phenotypes and 240 to score their interactions with pharmacological factors.
241

Competitive-aging experiments provide replicable estimates of survivorship 242
To systematically assess the technical replicability of the competitive-aging method, we 243 measured the CLS of ten mutants and reference strains in 96-well plates with multiple 244 independent replicate wells. Specifically, we measured relative survivorship of up to 245 seven replicate samples of each one of the ten deletion mutants together with 31 wild-246 type reference competitions in a 96-well plate (Figure 3A) ; the entire experiment was 247 carried two times: one experiment with three replicate plates and the second one with 248 two replicate plates. We validated our results with another large-scale method that 249 provides precise estimates of survivorship ( Figure 3B) . In particular, we measured CLS 250 of the same array of mutants and wild-type strains using an established high-throughput 251 method that is based in the changes of outgrowth kinetics of aging monocultures 252 (Murakami et al., 2008; Jung et al., 2015) . Qualitative inspection showed that both 253 methods correctly scored those mutants with known CLS effect (Fabrizio et al., 2001; 254 Fabrizio and Longo, 2003) . Specifically rim15 and hap3 had reduced survivorship, 255 while ras2 and gln3 showed increased lifespan compared to wild type.
256
To quantitatively contrast the replicability of both experimental approaches, we fitted 257 decay curves from the outgrowth kinetics experiments to an exponential model. We Figure S1 ). Likewise, when looking at the correlation of quantitative 264 data resulting from independent replicates, we found equivalent correlation coefficients 265 between replicates of each of the two approaches, showing that competitive-aging is as 266 replicable as the outgrowth-kinetics method (Supplementary Figure S1 ). We note that 267 gln3 was not included in one of the experiments, and that the ras2 was atypically 268 noisy in one of the outgrowth-kinetics replicates (not shown); hence these strains were 269 conservatively excluded from this analysis to prevent overestimation of the intra-and 270 inter-batch variability of the outgrowth-kinetics approach. Together, these results
271
indicate that the competition-based method is highly and at least as replicable as the 272 established method, despite inherent variation of different experimental batches.
273
We looked closer into the distribution of effects of all deletion mutants in five replicates, 274 as determined by the two experimental approaches (Figure 2C) . Competitive-aging 275 screening showed higher dynamic range but also higher variability. Deletion of rim15 276 consistently showed strong short-lived phenotypes with both approaches, while milder 277 short-lived phenotypes of hap3, ste12, msn4, and msn2 were also scored in most Figure S2 ). Thus, we conclude that including 6 to 293 10 reference samples is enough to provide a robust description of relative-CLS 294 phenotypes in large-scale genetic analyses of mutants, environments, and their 295 interactions.
296
Finally, we used this data set to evaluate the influence of the growth rate of the mutants 297 in the context of our competitive-aging method and multiple-regression model, which 298 includes parameter . Importantly, we observed that the model correctly identified 299 mutants with growth defects, as measured by independent culture outgrowths 300 (Supplementary Figure S3) ; hence, this parameter may enhance a more accurate 301 quantification of relative survivorship of deletion strains. To compare the estimation of 302 the effects on survivorship upon introduction of the parameter, the data was fitted 303 assuming =0 in all mutant-wild-type competitions; we observed that the difference in 304 16 the estimation of when was included was modest, but mostly explainable by . As 305 expected, the relative survivorship of slow-growth mutants (rim15, gln3, and ras2) 306 was underestimated when differences in growth rate were not taken into account 307 (Supplementary Figure S3 ). These results indicate that multiple-regression model 308 optimizes data analysis, especially in screens including mutants with impaired 309 exponential growth. and without the lifespan-extending drug metformin. 320 We confirmed that the CLS of WT reference samples of yeast increased significantly 321 from a half life of 10.7 to 15.5 days when treated with 40mM metformin (Figure 4A ; 322 p<10 -9 , Wilcoxon rank sum test). Next, we used our competitive-aging approach to 323 measure the CLS of an array of 76 knockout strains aged with or without metformin 324 (random selection of strains from the yeast deletion collection). In both conditions, we S4). We also confirmed that parameter predicted actual growth rates and resulted in a 328 modest correction of , as expected (Supplementary Figure S5) . 329 A direct quantitative comparison of CLS phenotypes under both conditions is shown in 330 Figure 4B (see Supplementary Figure S6 for data rescaling). Most samples were found 331 to fall close to the diagonal; namely the phenotypic effect of the knockout relative to WT 332 was similar under both conditions. The phenotypes of 21 of the 76 knockouts (27%) 333 were significantly different when treated with metformin (Supplementary Figure S7 ; t-334 test, p<0.05). Mutants with significantly-different phenotypes are potential gene-drug 335 interactions, especially those instances with large deviations from the expectation. In 336 many cases, we observed that metformin alleviated or even reverted the short-lifespan 337 effects of the gene deletion, with pep1, die2, and alg3 being the most extreme 338 instances. In only one mutant, lsc2, the drug significantly aggravated the relative short-339 lived gene-deletion phenotype. On the opposite scenario, the nominal long-lived 340 phenotype of certain mutants was rendered neutral or closer to neutral with the 341 metformin treatment (eg. hsv2, ubp13, and ubp5) . 342 We aimed to validate some of the potential gene-drug interactions identified in our 343 screen, focusing on eight mutants with large deviation from the expectation. First, we 344 measured the CLS of wild-type and gene-deletion strains with or without metformin, 345 using the outgrowth OD-kinetics approach (Supplementary Figure S7) . A clear effect of 346 metformin treatment on the CLS phenotype was evident for pep1, die2, and alg3; in 347 these cases the short-lifespan phenotype of the mutant was suppressed or alleviated by 348 metformin. We carried out live/dead staining of stationary-phase cells on these three 349 strains, which confirmed gene-drug interactions (Figure 4C) . The identified interactions, (Murakami et al., 2008; Jung et al., 2015) . Finally, using this enhanced method and data 376 analysis in a proof-of-principle experiment, we were able to unravel significant gene-377 drug interactions in an array of gene-deletions strains subjected to the lifespan-378 extending drug metformin.
379
Early CLS genome-wide screens were based on large pools of gene deletions followed 20 more strains can be tested in parallel (Jung et al., 2015 (Jung et al., , 2018 . There is still the issue 393 that mild environmental variation can affect separate cultures differently, that could lead 394 to low reproducibility (Burtner et al., 2011) ; for instance, strains may reach stationary 395 phase at different times after inoculation. In this regards, competitive-aging provides a 396 direct phenotypic comparison and, arguably, more consistent results, given that the 397 mutant population of interest is aged with an internal reference strain under the exact 398 same microenvironment. Importantly, competitive-aging can also be carried out in multi-399 well plates, enabling high-throughput experimental setups.
400
One of the inherent drawbacks of the competitive-aging method is that no absolute 401 death-rate information is provided, which can be easily solved thorough characterization 402 of the wild-type strain in monoculture, as we have shown. Likewise, the dynamic range methods, such as live/dead staining. 411 We have illustrated the potential of competitive-aging screening by characterizing an 412 array of yeast deletion strains exposed to metformin. A number of lifespan-extending 413 pharmacological interventions are already being tested for age-related diseases in 414 humans, even when the mechanisms underlying their beneficial effects are frequently 415 21 not fully understood (Mullard, 2018; Zimmermann et al., 2018) . Given that lifespan is a curves of wild-type (light colors) and gene-deletion (dark colors) strains in nominal SC medium (green) or SC with metformin (orange); 95% CI were calculated from at least three replicates (shaded area). The interaction between metformin and all three genedeletions was scored significant by two-way ANOVA tests of the death rates (***p< 0.01).
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Supplementary Note 1. Development and implementation of a linear model to calculate relative survival of mutant strains in competitive-aging cultures
To obtain relative survivorship of competitive-aging cultures we modeled WT and mutant populations with initial sizes and and declining trough time in stationary phase at constant exponential rates and After days, the sizes of the remaining viable populations are and . In every outgrowth sampling, we inoculated small volumes of this aged coculture onto fresh medium, in which both populations resume cell division and grow exponentially at rates and At any outgrowth, the population sizes after hours are and . Given that both strains are aged and grown in co-culture, the relationship between the sizes of their populations at any time, , during the outgrowth is:
As shown in Figure S1 , the measurements of CFP and RFP signals are proportional to and , therefore, the experimental measurements of each well, are equal to the linear equation:
We run a multiple linear regression where we fit the data obtained from measuring bulk RFP signal (RFP), and bulk CFP signal (CFP) in the outgrowth cultures in fresh medium sampled by inoculating from aging stationary phase co-cultures. The first step is to subtract auto-fluorescence RFP raw from WT CFP as a function of the OD 600 from all RFP raw measurements; the same is done for CFP raw from WT RFP . We keep outgrowth measurements for days in which we observe an increase in both RFP raw and CFP raw . This leaves us with the RFP and CFP quantities that should be a function of the death and growth rates ( and ) . For each measured well, , we Figure S2 . Variation in decreases with the number of reference samples used. Thirty-one WT RFP +WT CFP reference competitions were used in each plate. To estimate the effects of increasing number of reference samples, the model was fed with different numbers of reference wells and the reminder control samples were treated as additional mutant samples. For each given number of reference samples, 100 permutations were randomly selected and the selection coefficient ( ) of all mutant strains was calculated accordingly. A, The variation using different permutations was quantified as the standard deviation of each mutant sample; the average standard deviation of of all mutant samples is shown as a function of the number of reference samples in the model. B, The fit to the model was calculated along with the 95% CIs; the difference between the upper and lower CI bounds is plotted against the number of reference samples added to the model. Figure S3 . The parameter corrects effects of differential growth rates that otherwise affect relative survivorship, . A, The actual growth rate at exponential phase of gene-deletion strains measured as average increase in OD 600 with time (n=6-7), compared to the modeled parameter . B, Scatter plot showing the average value from 3-5 replicates with parameter is included in the multiple linear regression (horizontal axis) and when the regression is run without (S woG , vertical axis). C, The mild difference between calculations of showed in panel B is mostly explained by changes in the parameter . Figure S4 . The relative survivorship, , is well replicated within the same experiment (replicates 'A' and 'B', or 'C' and 'D') and between different experiments (#1 and #2), both without (green) and with metformin (orange). Left and central panels show single data points comparing two replicate plates, while the right panel shows the comparison of the averaged data of two replicates within each independent experiment. The Pearson correlation coefficients are shown in each panel. Figure S5 . The parameter corrects effects of differential growth rates that otherwise affect relative survivorship, . A, Box plots of the calculated for mutants with reduced fitness or without effects as previously reported (Costanzo et al. 2010) . Deleterious knockouts, (fitness f<0.95, n=10) usually have a more negative value than neutral knockouts without known growth defects (f≥0.95, n=67) (p=0.0014, Wilcoxon rank sum test). B, Scatter plot showing the obtained value with the parameter is included in the multiple linear regression (horizontal axis) and when the regression runs without (S woG , vertical axis). C, The difference between calculations of showed in panel A is mostly explained by average changes in the parameter . Figure S6 . Relative survivorship (rS) data rescaling. To quantitatively compare the relative phenotypes between two conditions of different WT phenotype, data were rescaled to a dimensionless relative survival parameter, . A, The death rates of the WT without (green) and with metformin (orange) were calculated by fitting to an exponential function the percent survival at different days of aging. Data points were from ten replicate samples in four replicate experiments (n=39 with metformin and n=40 for SC); lines are the average fits. B, The relative survival shows a bias between the two conditions (left); the rescaled survivorship parameter provides a better comparison under two conditions in which the WT dies at different rates (right). Specifically, relative survivorship was rescaled with the formula = −log (1 − ) using the average wild-type death rate obtained in each plate. Figure S7 . Candidate gene-drug interactions and validation. A, Plot shows individual and average measurements of of strains with differential phenotypic effects (p<0. 05, t-test) . Gray diagonal lines are used to visualize the sign of the gene-drug interaction. B, Validation of gene-drug interactions using the OD kinetics method. Survival curves were determined through aging monocultures of eight gene-deletion strains with some of the most extreme short-or long-lived phenotypes in SC, including candidate gene-drug interactions. Average percentage of survivorship is shown for the wild-type (solid lines) and gene-deletion strains (dashed lines) in both conditions, SC (green) and SC+Metformin (orange); error bars indicate the S.E.M (n=4).
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